Citations (75)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Qiang Chen & Huafang Lai. (2013) Plant-derived virus-like particles as vaccines. Human Vaccines & Immunotherapeutics 9:1, pages 26-49.
Read now
Read now
António Roldão, Maria Candida M Mellado, Leda R Castilho, Manuel JT Carrondo & Paula M Alves. (2010) Virus-like particles in vaccine development. Expert Review of Vaccines 9:10, pages 1149-1176.
Read now
Read now
Mary Hoelscher, Shivaprakash Gangappa, Weimin Zhong, Lakshmi Jayashankar & Suryaprakash Sambhara. (2008) Vaccines against epidemic and pandemic influenza. Expert Opinion on Drug Delivery 5:10, pages 1139-1157.
Read now
Read now
Yu-Chen Hu, Kun Yao & Tzong-Yuan Wu. (2008) Baculovirus as an expression and/or delivery vehicle for vaccine antigens. Expert Review of Vaccines 7:3, pages 363-371.
Read now
Read now
Pritish K Tosh & Gregory A Poland. (2008) Emerging vaccines for influenza. Expert Opinion on Emerging Drugs 13:1, pages 21-40.
Read now
Read now
Articles from other publishers (70)
Ghada Elfayres, Ricky Raj Paswan, Laura Sika, Marie-Pierre Girard, Soumia Khalfi, Claire Letanneur, Kéziah Milette, Amita Singh, Gary Kobinger & Lionel Berthoux. (2023) Mammalian cells-based platforms for the generation of SARS-CoV-2 virus-like particles. Journal of Virological Methods 322, pages 114835.
Crossref
Crossref
Junyao He, Linying Yu, Xiaodi Lin, Xiaoyan Liu, Yanming Zhang, Fan Yang & Wen Deng. (2022) Virus-like Particles as Nanocarriers for Intracellular Delivery of Biomolecules and Compounds. Viruses 14:9, pages 1905.
Crossref
Crossref
Wan Lu, Zhuangzhuang Zhao, Yao-Wei Huang & Bin Wang. (2022) Review: A systematic review of virus-like particles of coronavirus: Assembly, generation, chimerism and their application in basic research and in the clinic. International Journal of Biological Macromolecules 200, pages 487-497.
Crossref
Crossref
Izzat F.B.M Suffian & Khuloud T. Al-Jamal. (2022) Bioengineering of virus-like particles as dynamic nanocarriers for in vivo delivery and targeting to solid tumours. Advanced Drug Delivery Reviews 180, pages 114030.
Crossref
Crossref
Noelle Colant, Beatrice Melinek, Stefanie Frank, William Rosenberg & Daniel G. Bracewell. (2021) Escherichia coli-Based Cell-Free Protein Synthesis for Iterative Design of Tandem-Core Virus-Like Particles. Vaccines 9:3, pages 193.
Crossref
Crossref
Teshome Mebatsion. 2021. Viral Vectors in Veterinary Vaccine Development. Viral Vectors in Veterinary Vaccine Development
3
12
.
De-E Liu, Xiangjie Yan, Jinxia An, Jianbiao Ma & Hui Gao. (2020) Construction of traceable cucurbit[7]uril-based virus-mimicking quaternary complexes with aggregation-induced emission for efficient gene transfection. Journal of Materials Chemistry B 8:33, pages 7475-7482.
Crossref
Crossref
Steffen Zobel-Roos, Axel Schmidt, Fabian Mestmäcker, Mourad Mouellef, Maximilian Huter, Lukas Uhlenbrock, Martin Kornecki, Lara Lohmann, Reinhard Ditz & Jochen Strube. (2019) Accelerating Biologics Manufacturing by Modeling or: Is Approval under the QbD and PAT Approaches Demanded by Authorities Acceptable Without a Digital-Twin?. Processes 7:2, pages 94.
Crossref
Crossref
Jens Schumacher, Tijana Bacic, René Staritzbichler, Matin Daneschdar, Thorsten Klamp, Philipp Arnold, Sabrina Jägle, Özlem Türeci, Jürgen Markl & Ugur Sahin. (2018) Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide. Journal of Nanobiotechnology 16:1.
Crossref
Crossref
Claudia Montagna, Gianluca Petris, Antonio Casini, Giulia Maule, Gian Marco Franceschini, Ilaria Zanella, Luciano Conti, Francesca Arnoldi, Oscar R. Burrone, Lorena Zentilin, Serena Zacchigna, Mauro Giacca & Anna Cereseto. (2018) VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9. Molecular Therapy - Nucleic Acids 12, pages 453-462.
Crossref
Crossref
Ivonne González-Gamboa, Pilar Manrique, Flora Sánchez & Fernando Ponz. (2017) Plant-made potyvirus-like particles used for log-increasing antibody sensing capacity. Journal of Biotechnology 254, pages 17-24.
Crossref
Crossref
Izzat Fahimuddin Bin Mohamed Suffian, Mitla Garcia-Maya, Paul Brown, Tam Bui, Yuya Nishimura, Amir Rafiq Bin Mohammad Johari Palermo, Chiaki Ogino, Akihiko Kondo & Khuloud T. Al-Jamal. (2017) Yield Optimisation of Hepatitis B Virus Core Particles in E. coli Expression System for Drug Delivery Applications. Scientific Reports 7:1.
Crossref
Crossref
Izzat Fahimuddin Bin Mohamed Suffian, Julie Tzu-Wen Wang, Naomi O. Hodgins, Rebecca Klippstein, Mitla Garcia-Maya, Paul Brown, Yuya Nishimura, Hamed Heidari, Sara Bals, Jane K. Sosabowski, Chiaki Ogino, Akihiko Kondo & Khuloud T. Al-Jamal. (2017) Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo. Biomaterials 120, pages 126-138.
Crossref
Crossref
Hotcherl Jeong & Baik Lin Seong. (2017) Exploiting virus-like particles as innovative vaccines against emerging viral infections. Journal of Microbiology 55:3, pages 220-230.
Crossref
Crossref
Parham Sahandi Zangabad, Mahdi Karimi, Fatemeh Mehdizadeh, Hedieh Malekzad, Alireza Ghasemi, Sajad Bahrami, Hossein Zare, Mohsen Moghoofei, Amin Hekmatmanesh & Michael R. Hamblin. (2017) Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger. Nanoscale 9:4, pages 1356-1392.
Crossref
Crossref
A. Roldão, A.C. Silva, M.C.M. Mellado, P.M. Alves & M.J.T. Carrondo. 2017. Comprehensive Biotechnology. Comprehensive Biotechnology
633
656
.
Mikyung Yu, Jun Wu, Jinjun Shi & Omid C. Farokhzad. (2016) Nanotechnology for protein delivery: Overview and perspectives. Journal of Controlled Release 240, pages 24-37.
Crossref
Crossref
Naroa Serna, María Virtudes Céspedes, Paolo Saccardo, Zhikun Xu, Ugutz Unzueta, Patricia Álamo, Mireia Pesarrodona, Alejandro Sánchez-Chardi, Mónica Roldán, Ramón Mangues, Esther Vázquez, Antonio Villaverde & Neus Ferrer-Miralles. (2016) Rational engineering of single-chain polypeptides into protein-only, BBB-targeted nanoparticles. Nanomedicine: Nanotechnology, Biology and Medicine 12:5, pages 1241-1251.
Crossref
Crossref
Gaowei Hu, Naidong Wang, Wanting Yu, Zhanfeng Wang, Yawen Zou, Yan Zhang, Aibing Wang, Zhibang Deng & Yi Yang. (2016) Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B. Vaccine 34:16, pages 1896-1903.
Crossref
Crossref
Zeinab Shirbaghaee & Azam Bolhassani. (2016) Different applications of virus-like particles in biology and medicine: Vaccination and delivery systems. Biopolymers 105:3, pages 113-132.
Crossref
Crossref
Tobias W. Giessen & Pamela A. Silver. (2016) Encapsulation as a Strategy for the Design of Biological Compartmentalization. Journal of Molecular Biology 428:5, pages 916-927.
Crossref
Crossref
Manzoor M KhanManzoor M. Khan. 2016. Immunopharmacology. Immunopharmacology
363
396
.
Dan Yan, Yan-Quan Wei, Hui-Chen Guo & Shi-Qi Sun. (2015) The application of virus-like particles as vaccines and biological vehicles. Applied Microbiology and Biotechnology 99:24, pages 10415-10432.
Crossref
Crossref
D. Zhao, B. Sun, H. Jiang, S. Sun, F.T. Kong, Y. Ma, L. Jiang, L. Bai, X. Chen, P. Yang, C. Liu, Y. Xu, W. Su, W. Kong, F. Xu & C. Jiang. (2015) Enterovirus71 virus-like particles produced from insect cells and purified by multistep chromatography elicit strong humoral immune responses in mice. Journal of Applied Microbiology 119:4, pages 1196-1205.
Crossref
Crossref
Torbjörn Ramqvist, Nathalie Grün & Tina Dalianis. (2015) Human Papillomavirus and Tonsillar and Base of Tongue Cancer. Viruses 7:3, pages 1332-1343.
Crossref
Crossref
Yu-Li Lin, Yu-Chen Hu, Cheng-Chao Liang, Shih-Yeh Lin, Yu-Chih Liang, Hui-Ping Yuan & Bor-Luen Chiang. (2014) Enterovirus-71 Virus-Like Particles Induce the Activation and Maturation of Human Monocyte-Derived Dendritic Cells through TLR4 Signaling. PLoS ONE 9:10, pages e111496.
Crossref
Crossref
Emily P. Wen, Ronald Ellis & Narahari S. PujarBernd Kalbfuss‐Zimmermann & Udo Reichl. 2014. Vaccine Development and Manufacturing. Vaccine Development and Manufacturing
97
180
.
TINA DALIANIS. (2014) Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy. International Journal of Oncology 44:6, pages 1799-1805.
Crossref
Crossref
Mengmeng Chen, Yanhua Song, Zhiyu Fan, Ping Jiang, Bo Hu, Jiabin Xue, Houjun Wei & Fang Wang. (2014) Immunogenicity of different recombinant rabbit hemorrhagic disease virus-like particles carrying CD8+ T cell epitope from chicken ovalbumin (OVA). Virus Research 183, pages 15-22.
Crossref
Crossref
Irena Voráčková, Pavel Ulbrich, William E. Diehl & Tomáš Ruml. (2013) Engineered retroviral virus-like particles for receptor targeting. Archives of Virology 159:4, pages 677-688.
Crossref
Crossref
Shih-Yeh Lin, Yao-Chi Chung, Hsin-Yi Chiu, Wei-Kuang Chi, Bor-Luen Chiang & Yu-Chen Hu. (2014) Evaluation of the stability of enterovirus 71 virus-like particle. Journal of Bioscience and Bioengineering 117:3, pages 366-371.
Crossref
Crossref
Linda H.L. Lua, Natalie K. Connors, Frank Sainsbury, Yap P. Chuan, Nani Wibowo & Anton P.J. Middelberg. (2014) Bioengineering virus-like particles as vaccines. Biotechnology and Bioengineering 111:3, pages 425-440.
Crossref
Crossref
Feng Li & Qiangbin Wang. (2013) Fabrication of Nanoarchitectures Templated by Virus‐Based Nanoparticles: Strategies and Applications. Small 10:2, pages 230-245.
Crossref
Crossref
Sophia Pavlova, Regina Feederle, Kathrin Gärtner, Walter Fuchs, Harald Granzow & Henri-Jacques Delecluse. (2013) An Epstein-Barr Virus Mutant Produces Immunogenic Defective Particles Devoid of Viral DNA. Journal of Virology 87:4, pages 2011-2022.
Crossref
Crossref
Peter Pushko, Paul Pumpens & Elmars Grens. (2013) Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures. Intervirology 56:3, pages 141-165.
Crossref
Crossref
Cristina S Borio, Marcos F Bilen, Marcelo H Argüelles, Sandra E Goñi, Javier A Iserte, Graciela Glikmann & Mario E Lozano. (2012) Antigen vehiculization particles based on the Z protein of Junin virus. BMC Biotechnology 12:1.
Crossref
Crossref
Wei Wang, Xiaochun Chen, Chunyi Xue, Yichao Du, Lishan Lv, Qiliang Liu, Xiaoming Li, Yun Ma, Huifang Shen & Yongchang Cao. (2012) Production and immunogenicity of chimeric virus-like particles containing porcine reproductive and respiratory syndrome virus GP5 protein. Vaccine 30:49, pages 7072-7077.
Crossref
Crossref
Tina Dalianis. (2012) Immunotherapy for polyomaviruses: opportunities and challenges. Immunotherapy 4:6, pages 617-628.
Crossref
Crossref
Weilong Shang, Jie Liu, Jie Yang, Zhen Hu & Xiancai Rao. (2012) Dengue virus-like particles: construction and application. Applied Microbiology and Biotechnology 94:1, pages 39-46.
Crossref
Crossref
Yu-Li Lin, Chun-I Yu, Yu-Chen Hu, Tze-Jiun Tsai, Yin-Chieh Kuo, Wei-Kuang Chi, Ae-Ning Lin & Bor-Luen Chiang. (2012) Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles. Vaccine 30:7, pages 1305-1312.
Crossref
Crossref
Wan-Shoo Cheong, Michiko Hyakumura, Lilly Yuen, Nadia Warner, Stephen Locarnini & Hans J. Netter. (2012) Modulation of the immunogenicity of virus-like particles composed of mutant hepatitis B virus envelope subunits. Antiviral Research 93:2, pages 209-218.
Crossref
Crossref
Maria Trovato. (2012) Delivery strategies for novel vaccine formulations. World Journal of Virology 1:1, pages 4.
Crossref
Crossref
Maria Candida M. Mellado, Manuel J.T. Carrondo & Paula M. Alves. 2012. Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT), Dublin, Ireland, June 7-10, 2009. Proceedings of the 21st Annual Meeting of the European Society for Animal Cell Technology (ESACT), Dublin, Ireland, June 7-10, 2009
651
665
.
Hao Feng, Meng Liang, Hua-lei Wang, Tao Zhang, Ping-sen Zhao, Xing-jia Shen, Ren-zhou Zhang, Gui-qiu Hu, Yu-wei Gao, Cheng-yu Wang, Tie-cheng Wang, Wei Zhang, Song-tao Yang & Xian-zhu Xia. (2011) Recombinant canine parvovirus-like particles express foreign epitopes in silkworm pupae. Veterinary Microbiology 154:1-2, pages 49-57.
Crossref
Crossref
Stanislaw J. KaczmarczykKalavathy SitaramanHoward A. Young, Stephen H. Hughes & Deb K. Chatterjee. (2011) Protein delivery using engineered virus-like particles. Proceedings of the National Academy of Sciences 108:41, pages 16998-17003.
Crossref
Crossref
David Franco, Weimin Liu, David F Gardiner, Beatrice H Hahn & David D Ho. (2011) CD40L-Containing Virus-Like Particle as a Candidate HIV-1 Vaccine Targeting Dendritic Cells. JAIDS Journal of Acquired Immune Deficiency Syndromes 56:5, pages 393-400.
Crossref
Crossref
Alejandro Brun, Juan Bárcena, Esther Blanco, Belén Borrego, Daniel Dory, José M. Escribano, Ghislaine Le Gall-Reculé, Javier Ortego & Linda K. Dixon. (2011) Current strategies for subunit and genetic viral veterinary vaccine development. Virus Research 157:1, pages 1-12.
Crossref
Crossref
Thorsten Klamp, Jens Schumacher, Georg Huber, Christoph Kühne, Ulrich Meissner, Abderraouf Selmi, Thomas Hiller, Sebastian Kreiter, Jürgen Markl, Özlem Türeci & Ugur Sahin. (2011) Highly Specific Auto-Antibodies against Claudin-18 Isoform 2 Induced by a Chimeric HBcAg Virus-Like Particle Vaccine Kill Tumor Cells and Inhibit the Growth of Lung Metastases. Cancer Research 71:2, pages 516-527.
Crossref
Crossref
Joan Domingo-Espín, Ugutz Unzueta, Paolo Saccardo, Escarlata Rodríguez-Carmona, José Luís Corchero, Esther Vázquez & Neus Ferrer-Miralles. 2011. Nanoparticles in Translational Science and Medicine. Nanoparticles in Translational Science and Medicine
247
298
.
A. Roldão, A.C. Silva, M.C.M. Mellado, P.M. Alves & M.J.T. Carrondo. 2011. Comprehensive Biotechnology. Comprehensive Biotechnology
625
649
.
Regina Feederle, Emmalene J Bartlett & Henri-Jacques Delecluse. (2010) Epstein-Barr virus genetics: talking about the BAC generation. Herpesviridae 1:1.
Crossref
Crossref
Cheng-Yu Chung, Chi-Yuan Chen, Shih-Yeh Lin, Yao-Chi Chung, Hsin-Yi Chiu, Wei-Kuang Chi, Yu-Li Lin, Bor-Luen Chiang, Wei-Jheng Chen & Yu-Chen Hu. (2010) Enterovirus 71 virus-like particle vaccine: Improved production conditions for enhanced yield. Vaccine 28:43, pages 6951-6957.
Crossref
Crossref
Angelika B. Riemer, Derin B. Keskin, Guanglan Zhang, Maris Handley, Karen S. Anderson, Vladimir Brusic, Bruce Reinhold & Ellis L. Reinherz. (2010) A Conserved E7-derived Cytotoxic T Lymphocyte Epitope Expressed on Human Papillomavirus 16-transformed HLA-A2+ Epithelial Cancers. Journal of Biological Chemistry 285:38, pages 29608-29622.
Crossref
Crossref
Maurizio Federico. (2010) Virus-like particles show promise as candidates for new vaccine strategies. Future Virology 5:4, pages 371-374.
Crossref
Crossref
Elena García-Fruitós, Joaquín Seras-Franzoso, Esther Vazquez & Antonio Villaverde. (2010) Tunable geometry of bacterial inclusion bodies as substrate materials for tissue engineering. Nanotechnology 21:20, pages 205101.
Crossref
Crossref
Ningyan Zhang & Zhiqiang An. 2010. Manual of Industrial Microbiology and Biotechnology. Manual of Industrial Microbiology and Biotechnology
145
156
.
Arun K. Dhar, Robert M. Bowers, Christopher G. Rowe & F.C. Thomas Allnutt. (2010) Expression of a foreign epitope on infectious pancreatic necrosis virus VP2 capsid protein subviral particle (SVP) and immunogenicity in rainbow trout. Antiviral Research 85:3, pages 525-531.
Crossref
Crossref
Claudia Muratori, Roberta Bona & Maurizio Federico. 2010. Lentivirus Gene Engineering Protocols. Lentivirus Gene Engineering Protocols
111
124
.
A. Naskalska, E. Szolajska, L. Chaperot, J. Angel, J. Plumas & J. Chroboczek. (2009) Influenza recombinant vaccine: Matrix protein M1 on the platform of the adenovirus dodecahedron. Vaccine 27:52, pages 7385-7393.
Crossref
Crossref
Zhongwei Niu, Saswat Kabisatpathy, Jinbo He, L. Andrew Lee, Jianhua Rong, Lin Yang, Godfrey Sikha, Branko N. Popov, Todd S. Emrick, Thomas P. Russell & Qian Wang. (2010) Synthesis and characterization of bionanoparticle—Silica composites and mesoporous silica with large pores. Nano Research 2:6, pages 474-483.
Crossref
Crossref
E. Crisci, H. Almanza, I. Mena, L. Córdoba, E. Gómez-Casado, J.R. Castón, L. Fraile, J. Bárcena & M. Montoya. (2009) Chimeric calicivirus-like particles elicit protective anti-viral cytotoxic responses without adjuvant. Virology 387:2, pages 303-312.
Crossref
Crossref
L. Andrew Lee, Zhongwei Niu & Qian Wang. (2010) Viruses and virus-like protein assemblies—Chemically programmable nanoscale building blocks. Nano Research 2:5, pages 349-364.
Crossref
Crossref
Luhong Hou, Hao Wu, Limei Xu & Feng Yang. (2009) Expression and self-assembly of virus-like particles of infectious hypodermal and hematopoietic necrosis virus in Escherichia coli. Archives of Virology 154:4, pages 547-553.
Crossref
Crossref
David LiebowitzBin Lu. (2009) Making improvements in influenza vaccines: incremental change or transformational evolution?. Future Virology 4:2, pages 133-141.
Crossref
Crossref
Alfonso J. García-Piñeres, Allan Hildesheim, Lori Dodd, Troy J. Kemp, Jun Yang, Brandie Fullmer, Clayton Harro, Douglas R. Lowy, Richard A. Lempicki & Ligia A. Pinto. (2009) Gene Expression Patterns Induced by HPV-16 L1 Virus-Like Particles in Leukocytes from Vaccine Recipients. The Journal of Immunology 182:3, pages 1706-1729.
Crossref
Crossref
Virginie M.G. Renoux, Maxime J.J. Fleury, Latifa Bousarghin, Julien Gaitan, Pierre-yves Sizaret, Antoine Touzé & Pierre Coursaget. (2008) Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice. Vaccine 26:51, pages 6602-6607.
Crossref
Crossref
Henri-Jacques Delecluse, Regina Feederle, Uta Behrends & Josef Mautner. (2008) Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus. Seminars in Cancer Biology 18:6, pages 409-415.
Crossref
Crossref
Jan Frič, Martin Marek, Veronika Hrušková, Vladimír Holáň & Jitka Forstová. (2008) Cellular and humoral immune responses to chimeric EGFP-pseudocapsids derived from the mouse polyomavirus after their intranasal administration. Vaccine 26:26, pages 3242-3251.
Crossref
Crossref
Yao-Chi Chung, Mei-Shang Ho, Jaw-Chin Wu, Wei-Jheng Chen, Jen-Huang Huang, Szu-Ting Chou & Yu-Chen Hu. (2008) Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine 26:15, pages 1855-1862.
Crossref
Crossref
Manzoor M. KhanManzoor M. Khan. 2008. Immunopharmacology. Immunopharmacology
227
252
.